Bristol Myers Squibb uses the power of science to address some of the most challenging diseases of our time. Their focus on unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
Bristol Myers Squibb’s Global Product Development and Supply (GPS) group operates within an exceptionally complex and high-stakes environment. The group encompasses a wide range of critical functions — including Global Supply Chain, External Manufacturing, Global Quality, Global Engineering, and Finance — all working within a matrix structure that supports dozens of manufacturing and operational sites worldwide. With thousands of projects & initiatives running each year across diverse geographies and functional areas, the GPS organization faced increasing pressure to manage complexity while driving continuous improvement.
One of the primary challenges was overcoming the siloed nature of its business functions. Each function pursued its own initiatives, making it difficult to prioritize and coordinate improvement projects at a global scale. Leadership also had to respond to an enterprise-wide mandate to “do more with less,” meaning teams needed to deliver greater value with fewer resources — a significant challenge given the volume and criticality of the work being undertaken.
Making investment decisions was another pain point. The organization needed much clearer visibility into how initiatives aligned with broader strategic goals to ensure resources were being allocated effectively. At the same time, understanding resource and financial capacity — particularly when assessing the impact of launching new projects or making operational changes — was a persistent struggle.
While Bristol Myers Squibb’s Global Product Development and Supply group had a Portfolio Management Office (PMO) and several legacy tools in place, they knew a smarter, faster way of working was needed. Their tools lacked the advanced capabilities necessary to meet the demands of such a dynamic, regulated environment. Features like modern automation, robust resource planning, consolidation of ideation across sites and functions, and financial planning for programs were either missing or insufficient. Their goal was to move beyond aging systems and siloed processes — and embrace modern portfolio management with intelligent automation at the core. They wanted a more powerful, flexible solution to manage their portfolios with the clarity, speed, and precision required for a global biopharmaceutical leader.
Bristol Myers Squibb partnered with OnePlan to not just upgrade technology, but to rethink and streamline their cross-functional processes before implementing new technology. Together, we identified key process and organizational improvements that would set the foundation for lasting change. Then, OnePlan’s powerful platform was implemented to bring those improvements to life, sunsetting the older technology while maintaining the integration of core technologies required by separate user groups.
By integrating directly with Microsoft Project, OnePlan delivered a modern, flexible solution that revitalized how Bristol Myers Squibb managed projects and portfolios. With enhanced resource management, unified ideation, expanded financial planning, and strategic prioritization, teams were now able to align execution tightly with enterprise goals — and see it all through clear, comprehensive reporting.
– We configured and delivered a tailored strategic portfolio, program, and resource management solution with 20 Portfolio categories with more than 100 Sub-Portfolio categories in a structured hierarchy holding thousands of programs, projects, and resources.
– Stage Gate workflows accommodated the lifecycle of their Programs and Projects including notifications and approvals.
– A modern portfolio dashboard & reporting provides meaningful “one-pager” visuals with quick and easy real time access.
– We implemented robust Status tracking and trending algorithms, along with monthly status reports for visibility to the Executive Leadership Team.
– Risks, plus corresponding issues, decisions, etc, are incorporated directly into the Programs and Projects for more effective risk management, communication and decision making.
Today, Bristol Myers Squibb can:
By replacing and consolidating legacy tools with OnePlan’s modern, AI-powered platform, Bristol Myers Squibb gained a unified solution that streamlines operations, reduces IT overhead and eliminates silos.
